Kevin McAlpine has a diverse background in the pharmaceutical industry, currently serving as Senior Manager of Market Access Training for Rare Disease at Amgen since July 2025. Kevin has held various roles at Bristol Myers Squibb from November 2021 to October 2024, including Commercialization Learning Senior Manager for Immunology and Associate Director of Hematology Market Engagement. Previous experience includes roles at Otsuka Pharmaceutical Companies as Senior Neuroscience Account Manager, Reliant Pharmaceuticals as Professional Sales Representative, and a brief tenure at IQVIA in Cardiovascular Specialty Sales. Kevin achieved a notable increase in new prescriptions by over 200% within four months and has a proven track record in disseminating technological best practices.
This person is not in the org chart
This person is not in any teams
This person is not in any offices